Development and description of a decision analysis based decision support tool for stroke prevention in atrial fibrillation

被引:35
|
作者
Thomson, R [1 ]
Robinson, A [1 ]
Greenaway, J [1 ]
Lowe, P [1 ]
机构
[1] Med Sch Newcastle Upon Tyne, Dept Epidemiol & Publ Hlth, Sch Hlth Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
来源
QUALITY & SAFETY IN HEALTH CARE | 2002年 / 11卷 / 01期
关键词
D O I
10.1136/qhc.11.1.25
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: There is an increasing move towards clinical decision making that engages the patient, which has led to the development and use of decision aids to support better decisions. The treatment of patients in atrial fibrillation (AF) with warfarin to prevent stroke is a decision that is sensitive to patient preferences as shown by a previous decision analysis. Aim: To develop a computerised decision support tool, building upon a previous decision analysis, which would engage individual patient preferences in reaching a shared decision on whether to take warfarin to prevent stroke. Methods: The development process had two main phases: (1) the development phase which employed focus groups and repeated interviews with GPs/practice nurses and patients alongside an iterative development of a computerised tool; (2) the training and testing phase in which GPs and practice nurses underwent training in the use of the tool, including the use of simulated patients. The tool was then used in a feasibility study in a small number of patients with AF to inform the design of a subsequent randomised controlled trial. Results: The prototype tool had three components: (1) derivation of an individual patient's values for relevant health states using a standard gamble; (2) presentation/discussion of a patient's risks of stroke using the Framingham equation and the benefits/risks of warfarin from a systematic literature review; and (3) decision making component incorporating the outcome of a Markov decision analysis model. Older patients could be taken through the decision analysis based computerised tool, and patients and clinicians welcomed information on risks and benefits of treatments. The tool required time and training to use. Patients' decisions in the feasibility phase did not necessarily coincide with the output of the decision analysis model, but decision conflict appeared to be reduced and both patients and GPs were satisfied with the process. Conclusions: It is feasible to develop a decision analysis based computer software package that is acceptable to elderly patients and clinicians, but it requires time and expertise to use. It is most likely that a tool of this type will best be used by a small number of clinicians who have developed experience of its use and can maintain their skills.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 50 条
  • [31] Patient Decision Aids and Encounter Decision Aids Improve Shared Decision Making and Patient Knowledge About Stroke Prevention In Patients with Atrial Fibrillation
    Fagerlin, Angie
    Barnes, Geoffrey
    Cameron, Kenzie
    Cavanaugh, Kerri
    Crossley, George
    Greene, Tom
    Kansal, Preeti
    Montori, Victor
    Noseworthy, Peter
    Passman, Rod
    Roden, Dan
    Steinberg, Benjamin
    Witt, Daniel
    Ozanne, Elissa
    CIRCULATION, 2024, 150
  • [32] Computerized clinical decision support to improve stroke prevention therapy in primary care management of atrial fibrillation: a cluster randomized trial
    Cox, Jafna
    Hamilton, Laura
    Thabane, Lehana
    Foster, Gary
    MacKillop, James
    Xie, Feng
    Ciaccia, Antonio
    Choudhri, Shurjeel
    Nemis-White, Joanna
    Parkash, Ratika
    AMERICAN HEART JOURNAL, 2024, 273 : 102 - 110
  • [33] Clinical decision support for stroke prevention in atrial fibrillation (CDS-AF): a cluster randomized trial in the primary care setting
    Karlsson, L. O.
    Nilsson, S.
    Charitakis, E.
    Nilsson, L.
    Janzon, M.
    EUROPEAN HEART JOURNAL, 2017, 38 : 772 - 772
  • [34] Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation
    Thomson, R
    Parkin, D
    Eccles, M
    Sudlow, M
    Robinson, A
    LANCET, 2000, 355 (9208): : 956 - 962
  • [35] DEVELOPMENT OF A TAILORED LIFE-SUSTAINING TREATMENT DECISION SUPPORT TOOL FOR STROKE SURROGATE DECISION MAKERS
    Chen, Emily
    Arslanian-Engoren, Cynthia
    Newhouse, William
    Egleston, Diane
    Sahgal, Savina
    Yande, Aneesha
    Fagerlin, Angela
    Zahuranec, Darin
    MEDICAL DECISION MAKING, 2020, 40 (01) : E310 - E311
  • [36] Physician confidence, knowledge, and decision making surrounding stroke prevention and anticoagulation in nonvalvular atrial fibrillation
    Pape, GA
    Hunt, JS
    CIRCULATION, 2004, 109 (20) : E268 - E268
  • [37] Decision-making around antithrombotics for stroke prevention in atrial fibrillation: the health professionals' views
    Wang, Yishen
    Bajorek, Beata
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (04) : 985 - 995
  • [38] Shared decision making for stroke prevention in atrial fibrillation: study protocol for a randomized controlled trial
    Marleen Kunneman
    Megan E. Branda
    Peter A. Noseworthy
    Mark Linzer
    Bruce Burnett
    Sara Dick
    Gabriela Spencer-Bonilla
    Cara A. Fernandez
    Haeshik Gorr
    Mike Wambua
    Shelly Keune
    Claudia Zeballos-Palacios
    Ian Hargraves
    Nilay D. Shah
    Victor M. Montori
    Trials, 18
  • [39] Can Shared Decision Making Improve Stroke Prevention in Atrial Fibrillation? Implications of the Updated Guidelines
    Brand-McCarthy, Sarah R.
    Delaney, Rebecca K.
    Noseworthy, Peter A.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2020, 13 (03):
  • [40] Decision-making around antithrombotics for stroke prevention in atrial fibrillation: the health professionals’ views
    Yishen Wang
    Beata Bajorek
    International Journal of Clinical Pharmacy, 2016, 38 : 985 - 995